Cannabis Blog

California’s Legalization Movement Gets Generous Donation

Category: News | Posted on Fri, December, 18th 2015 by THCFinder

Sean Parker, creator of Napster and early investor in Facebook, is giving the California Marijuana Policy Project (MPP) an early Christmas present.

The generous tech billionaire and philanthropist recently announced he will match all donations to MPP, dollar-for-dollar, up to any amount, reported SFGate.

“We’re very excited about the generosity he’s shown,” Mason Tvert, MPP Communications Director, said. “This is someone who wants to see marijuana prohibition end and helped bring a lot of folks together, and now he’s putting his money where his mouth is.”

This is the latest in a series of Parker’s philanthropic acts, which include donations to cancer, diabetes and auto-immune research.

Parker, viewed as the driving force behind California’s Adult Use of Marijuana Act (AUMA), is part of a new generation of wealthy activists supporting such issues as ending mass incarceration and supporting drug reform, said Amanda Reiman, Marijuana Law and Policy Manager at Drug Policy Alliance.

Read More:


What strain are you smoking on today?

Category: Fun | Posted on Thu, December, 17th 2015 by THCFinder


DEA Allows Cannabis Imports to Facilitate the Big Pharma of Marijuana

Category: News | Posted on Thu, December, 17th 2015 by THCFinder

The U.S. Drug Enforcement Administration has all but refused to acknowledge lawful cannabis producers as part of legitimate commerce here in the United States, but that has not stopped the agency from working with corporate drug pushers in the importation of cannabis products to be used to facilitate the Big Pharma takeover of the medical marijuana industry.

A federal notice released earlier this month indicates that big government has given a New Jersey drug development company called Catalent Pharma Solutions permission to begin importing various forms of cannabis into the United States to be administered to patients in clinical trials. The “finished pharmaceutical products containing cannabis extracts” will be shipped to the company’s research facility in Kansas City, Missouri, which develops and tests medications in “oral dose forms.” 

Catalent’s Vice President of Corporate Strategy, Cornell Stamoran, recently told In-Pharm Technologist, a news source covering the happenings of the international pharmaceutical trade, there is “a growing need for special handling capabilities in pharmaceutical development due to evolving characteristics of pharmaceutical and biotechnology pipeline molecules” and “as these molecules transition to commercially approved products, similar complexities arise in production and distribution of commercial supplies.” 

Read More:


Half Baked: Munchies

Category: Videos | Posted on Thu, December, 17th 2015 by THCFinder



Blog Categories

Popular Articles

Latest Offers In Your Area
Recent Blog Posts
Download Our App!
11.4 Miles Away | Malibu,
29.5 Miles Away | La Puente, West,
29.5 Miles Away | La Puente, West,
April 19, 2018 | Category: Medical Marijuana
March 19, 2018 | Category: Medical Marijuana
February 20, 2018 | Category: Culture
Mobile Apps
Copyright 2018
All Rights Reserved.
Dispensaries      Strains      About Us      Friends      API / Widgets      Privacy Policy      Terms of Use      Investors      Contact Us